| Property | Value |
|---|
|
?:abstract
|
-
We compliment Xu et al. [1] for reporting an interesting case on renal infarction in patients with novel coronavirus disease 2019 (COVID-19), presumably due to hypercoagulable state associated with the infection. Documentation of such case would help the clinicians who involve in the management of patients with COVID-19 to consider renal infarction as one of the differential diagnoses of acute kidney injury. It was encouraging to observe that the condition of the patient improved upon initiation of therapeutic anticoagulation.
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
|
|
?:journal
|
-
American_journal_of_transplantation_:_official_journal_of_the_American_Society_of_Transplantation_and_the_American_Society_of_Transplant_Surgeons
|
|
?:license
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
-
Revascularization in COVID-19 patients with renal infarction.
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}